MEDICAL TECHNOLOGIES IN THE
GREATER MONTREAL AREA :
A BUOYANT SECTOR OF
ACTIVITY
November 2013
TABLE OF
SECTOR | MEDICAL TECHNOLOGIES
2
CONTENT
EXECUTIVE SUMMARY
3
REASONS TO INVEST IN GREATER MONTREAL
4
An ideal location to conquer the North-American market
5
Montreal, a hub in biomedical research and healthcare-related technologies
6
At the junction of IT and life sciences
8
Industry leaders, news and recent announcements
10
Skilled manpower from a diversified academic environment
An environment conducive to innovation
Incubators, business coaching and counselling
16
University based technology transfer organisations
17
The Quebec National Policy on Research and Innovation (PNRI)
18
A hot spot of open innovation and collaborative research
19
Metropolitan Montreal, a leading Venture Capital center in Canada
20
Competitive financial incentives
21
MONTRÉAL INTERNATIONAL : A PERSONAL TOUCH
24
EXECUTIVE
SECTOR | MEDICAL TECHNOLOGIES
3
SUMMARY
Perfect timing for Metropolitan Montreal :
•
Up to date medical technologies are needed to improve the quality of healthcare while
reducing costs and increasing accessibility in the context of aging population
•
The biomedical technology sector is maturing as multinational corporations settle in Montreal
following the acquisition of innovative platforms: Medtronic-Cryocath, ZimmerCAS, Elekta,
Masimo
•
Large investments are currently taking place in three new university hospital complexes
•
The healthcare systems of Quebec and of Canada are transiting towards informatics and
large scale data management; the electronic patient record is being implemented
A long tradition of excellence in biomedical research and in the execution of clinical trials
•
The Montreal cluster combines research institutes, public and private laboratories, suppliers,
CROs, service providers and innovative companies, all working in close interaction
A dense network of colleges and universities, including two faculties of medicine, four
schools of engineering and numerous research centers renown internationally
Strong support by the Quebec Government to innovation and innovative companies
•
Implementation of the National Policy on Research and Innovation (PNRI) ( 3,7 G$)
along seven strategic areas including: life science and personalized medicine
•
Funds for open innovation and projects carried out by research consortia
•
Highly competitive financial incentives
4
REASONS
TO INVEST
IN THE GREATER
MONTREAL REGION
THE GREATER MONTREAL AREA:
SECTOR | MEDICAL TECHNOLOGIES
5
AN IDEAL SITE TO CONQUER
THE NORTH AMERICAN MARKET
Direct access to the market of the North
American Free Trade Agreement (NAFTA),
representing approximately
●
460 million consumers
●
A total GDP of USD 17 trillion
A strategic location in North America
• Flying time less than 2 hours from
Toronto, Boston and New York
•
70 km from the U.S. border
High quality transportation infrastructure
Signing of the free trade agreement between
• Two international airports (Montreal-Trudeau
Canada and the European Union
and Montreal-Mirabel)
● Better harmonization of the regulatory
• One sea port amongst the busiest ports in
process
North America, open all year round and linked
● Increased commercial trade
to more than 100 countries
Economic engine of Quebec, representing
50% of the population, GDP and
employment in the province
●
Population :
nearly 4 M
●
Real GDP (in 2012) :
161 G ($ of 2007)
●
Employment :
nearly 2 M
Source : The Conference Board of Canada, 2013
• A major logistic hub linking port-rail-road-air
THE GREATER MONTREAL AREA:
SECTOR | MEDICAL TECHNOLOGIES
6
A HUB IN BIOMEDICAL RESEARCH
AND HEALTHCARE-RELATED TECHNOLOGIES
LONG TRADITION OF EXCELLENCE
EXPERTISE IN ENABLING
IN BIOMEDICAL RESEARCH
TECHNOLOGIES
●
●
Computer graphics and 3D animation
●
Medical imaging
Cluster made up of world-class universities,
research centers and university hospitals
●
Internationally renown center for conducting
clinical research
●
Information technology
●
Comprehensive research activities in:
●
Data management
●
Hosting servers and data warehousing
●
Systems engineering
●
Nanotechnologies & advanced materials

Cardiology

Neuroscience

Oncology

Geriatrics

Metabolic diseases & nutritional disorders

Genetic diseases & genomics

Biomedical engineering
A HUB IN BIOMEDICAL RESEARCH AND HEALTHCARE SCIENCE
SECTOR | MEDICAL TECHNOLOGIES
7
RESEARCH CENTERS AND INSTITUTES
RESEARCH
CENTERS LINKED TO HOSPITALS
●
Centre de recherche Fernand-Seguin
(Institut universitaire en santé mentale de
Montréal)
●
Centre hospitalier de l'Université de
Montréal (CHUM)
●
McGill University Health Center (MUHC)
●
CHU Sainte-Justine (pædiatric hospital)
●
Jewish General Hospital (Lady Davis
Institute)
●
Hôpital Maisonneuve-Rosemont
●
RESEARCH INSTITUTES
●
Centre for interdisciplinary research in
Rehabilitation of Greater Montreal (CRIR)
●
Montreal Cardiology Institute
●
Institut de réadaptation Gingras-Lindsay-deMontréal (IRGLM)
●
Institut de recherches cliniques de Montréal
(IRCM)
●
Douglas Mental Health University Institute
●
Institut de recherche Robert Sauvé en santé
et en sécurité du travail du Québec (IRSST)
Montreal Children Hospital
●
Institut du cancer de Montréal (ICM)
●
Hôpital du Sacré-Cœur
●
Montreal Chest Institute
●
Montreal Neurological Institute and Hospital
●
Institut universitaire de gériatrie de Montréal
●
Institut Philippe-Pinel de Montréal
Source : Montreal InVivo Interactive Map
http://www.montreal-invivo.com/web/la-grappe/cartographie/
THE GREATER MONTREAL AREA:
SECTOR | MEDICAL TECHNOLOGIES
8
AT THE JUNCTION OF IT AND LIFE SCIENCES
LIFE SCIENCES AND HEALTH
TECHNOLOGIES (LSHT)
INFORMATION AND COMMUNICATION
TECHNOLOGIES (ICT)
●
45,000 employments in 600 establishments
●
●
With more than 12,000 researchers and
professionals
More than 92,000 skilled employees in
nearly 5,000 organizations3
●
400 subsidiaries of foreign corporations4
●
12 500 positions in R-D activities5 :
●
In 300 public agencies and government-own
organisations1
●
235 companies including 80 subsidiaries of
foreign corporations2

7 500 researchers in centers own by
private corporations

5 000 researchers in more than 100
university research centers
1 : Statistics Canada 2012 and Expertise recherche Québec 2012
2 : http://www.montrealinternational.com/sciences-de-la-vie/
3 : Statistics Canada 2012
4 : http://www.montrealinternational.com/technologies-de-linformation-et-des-communications/
5 : http://www.montrealinternational.com/innovation-technologies-de-linformation-et-des-communications/
THE GREATER MONTREAL AREA:
SECTOR | MEDICAL TECHNOLOGIES
9
MULTIPLE BRIDGES BETWEEN SECTORS OF THE ECONOMY
CROSS-FERTILISATION
●
ICT (Information and Communication Technologies)  Telemedecine and e-health
●
Video games industry  virtual reality, training platforms, improving patient’s experience
●
Aeronautics  simulators, high precision machining and manufacturing
●
Genomics & bio-informatics  diagnostics, personalized medicine
●
Logistics  inventory management, optimization of logistic chains, traceability
MONTREAL, «VILLE UNESCO DU DESIGN»
●
A node of the UNESCO cities of design network (2006) – web site
●
Unique creativity centre (scenic arts, media arts and technology, industrial design)
●
Contribution of design and creativity to the medical technology sector :

Ergonomy, 3D simulation, motion tracking and ambient monitoring

Improving «patient’s experience», enriched health and life spaces
A HUB IN BIOMEDICAL RESEARCH AND MEDICAL TECHNOLOGY
SECTOR | MEDICAL TECHNOLOGIES
10
INDUSTRY LEADERS, NEWS AND ANNOUNCEMENTS
Kinova
 Loan from Invest Québec to support the company’s effort in commercializing its Jaco platform
on the U.S. and European markets. The JACO arm, for which the company holds several
patents, is the first three-fingered robotic arm designed to increase the functional independence
of motorized wheelchair users (October 2013).
Carré Technologies
 Official launching of the intelligent shirt Hexoskin, a high tech garment with integrated sensors
that captures body metrics including heart rate and pulse recovery, breathing rate and
acceleration. Hexoskin  offers an easy and more natural way of regularly capturing precise
physiological data (August 2013).
Emovi
 Emovi has signed a distribution agreement for the commercialisation overseas of KneeKG, a
unique system used for precisely measuring and documenting the knee joint function in an
outpatient setting. The KneeKG provides objective data regarding the function of the knee and
highlights deficiencies in gait associated with knee problems (September 2013).
EMcision International
 The company specializing in advanced radiofrequency-based medical devices used in surgery,
has announced that it has sold its first units of the Habib™ RF DUO 13 catheter - a new device
with immense potential to help abdominal cancer patients (August 2013).
Sources : Flash InVivo http://www.montreal-invivo.com/web/
and corporate internet sites
A HUB IN BIOMEDICAL RESEARCH AND MEDICAL TECHNOLOGY
SECTOR | MEDICAL TECHNOLOGIES
11
INDUSTRY LEADERS, NEWS AND ANNOUNCEMENTS (CONT’D)
Medtronic
 In 2012, the company announced an investment of 50 M$ in its Medtronic Cryocath division,
more specifically into its R&D Centre, in advanced training resources and in its manufacturing
unit. This follows the acquisition by the American multinational of the cryotherapy platform
developed in Montreal to treat different heart conditions such as cardiac arryhtmias.
Hoffmann-La Roche and the Montreal Cardiology Institute
 In April 2012, the Montreal Cardiology Institute has been designated a hub for translational
medicine devoted to cardiometabolic disease in the global network of the multinational
pharmaceutical company Roche. This novel approach aims at transposing results of clinical
research into personalized treatments for improving patients’ cardio-vascular health.
Piramal Life Sciences
 Following the acquisition of Biosyntech’s platform on biomaterials, the Indian-based
multinational has initiated the commercialisation of BST-CarGel, a novel surgical biopolymer
to be used for repairing knee cartilage. The gel, fluid at room temperature, is mixed in an OR
setting with aulogous blood and inserted into the patient’s cartilage where it thickens and
favours the reconstruction of damaged tissues.
Elekta
 In 2010, the Swedish group Elekta has acquired Resonant Medical, a company that has
developed a 3D echography technology to guide precisely radiotherapy equipment during
cancer treatment procedures.
Sources : Flash InVivo http://www.montreal-invivo.com/web/
and corporate internet sites
A HUB IN BIOMEDICAL RESEARCH AND MEDICAL TECHNOLOGY
SECTOR | MEDICAL TECHNOLOGIES
12
INDUSTRY LEADERS, NEWS AND ANNOUNCEMENTS (CONT’D)
Héma-Québec (web site)
 Héma-Québec's mission is to efficiently provide adequate quantities of safe, optimal blood
components, substitutes, human tissues and cord blood to meet the needs of all Quebecers. It
provides products and services in the fields of transfusion medicine and human tissue
transplantation.
 The only public cord blood bank in Canada, operated by Héma-Québec since 2004, has
increased its activities at a sustained pace both nationally and internationally. Since September
2012, Héma-Québec has been offering its cord blood units to the international community
through Bone Marrow Donors Worldwide (BMDW).
MEDEC
(web site)
 MEDEC is the national association created by and for the Canadian medical technology
industry. Its goals are to advance health outcomes for patients in Canada as well as the growth
and vibrancy of the industry in Canada while favoring access to proven, safe and innovative
medical technology developed by its member companies.
 With an office and increasing presence in Quebec, MEDEC is the primary source for advocacy,
information and education on the medical technology industry for members, the greater
healthcare community, industry partners and the general public.
 MEDEC strongly supports the recent announcement by the Government of Canada of the
successful conclusion of negotiations with the European Union of the surrounding
the Comprehensive Economic and Trade Agreement (CETA) which will boost commercial ties
between the two partners particularly the healthcare and medical technology sector.
SKILLED MANPOWER
SECTOR | MEDICAL TECHNOLOGIES
13
FROM A DIVERSIFIED ACADEMIC ENVIRONMENT
A large university network
●
11 academic institutions
●
More than 170 000 university students, of which 20 000 foreign students
The largest pool of new university graduates in Canada
40 000 graduates per year
The most multilingual population in Canada
●
50 % is bilingual
●
20 % is multilingual (three languages and more)
Engineering schools:
Faculty of Medicine:
École Polytechnique de Montréal
University of Montreal & McGill University
École de Technologie Supérieure
Management schools:
McGill University
HEC Montréal, UQAM,
Concordia University
Concordia & McGill
Sources : Association d’études canadiennes, 2007 ; Ministère de l’Éducation, du
Loisir et du Sport (MELS) du Québec, 2011 ; Statistique Canada, 2007 et 2012
SKILLED MANPOWER
SECTOR | MEDICAL TECHNOLOGIES
14
TRAINING AND RESEARCH IN BIOMEDICAL ENGINEERING
Biomedical Engineering Institute of U de M
McGill University - Department of Biomedical
Engineering
• Linked with École Polytechnique and the
University of Montreal
• A pioneer in North America, part of McGill
Faculty of Medicine
Research Objectives:
Research areas:
● Cardiac electrophysiology
●
Biomedical signals, systems and imaging
●
Biomechanics and biomaterials/
rehabilitation
●
Biomedical modelling and simulation
Web site
Research Centre in Biomedical Science and
Technologies (GRSTB)
A multidisciplinary regrouping of labs,
scientists and engineers from different
institutions
Web site
●
Signals, systems and modelling
●
Biomaterials and tissue engineering
●
Artifical cells and drug delivery systems
●
Lab-on-a-chip and biosensors
●
Nanoparticles, nanomedecine
●
Neuro-imaging
●
Personalized medicine
Web site
SKILLED MANPOWER
SECTOR | MEDICAL TECHNOLOGIES
15
TRAINING AND RESEARCH IN BIOMEDICAL ENGINEERING
Biomedical Engineering program of École
de technologie supérieure (ETS)
Concordia University – Office of research
Research axis:
●
Sensors and bio-opto-electronics
●
Biomechanics and biomaterials
●
Cardio-vascular diagnostics
●
Medical imaging and devices
●
Design, testing and manufacturing
●
Occupational health and safety
●
Cellular imaging
●
Telehealth, electronic patient records
●
Lab-on-a-chip and microfluidics; MEMS
Enabling technologies:
●
Nanomaterials and drug delivery
●
Software and informatics
●
●
Nanotechnologies
Mass spectrometry applied to biological studies
biologie
●
Prototyping and manufacturing
●
Robotics
Concordia Concordia – Centre PERFORM
●
Material science
●
Dedicated to new ways of researching better
health through prevention
●
Advanced clinical research facility available for
multidiciplinary, interinstitutional studies
Research themes:
Web site
Web site
Web site
AN ENVIRONMENT CONDUCIVE TO INNOVATION
SECTOR | MEDICAL TECHNOLOGIES
16
INCUBATORS, BUSINESS COACHING AND COUNSELLING
CTS (Campus des technologies de la santé)
●
CTS provides services, physical facilities, a
network of experts and programs for
companies of the medical sector developing
devices, instruments, systems and IT
Web site
CENTECH, ETS Business incubator
●
Currently has about fifty active businesses
●
Accepting projects of students and
graduates from the early stage of the
entrepreneurial process (emergence phase)
Web site
CQIB
●
Incubator for companies in LSHT, operated
in partnership with Laval Technopole
●
Access to infrastructure (equipment and
space), to consulting services and business
networks, to funding sources
Centre d’entreprises et d’innovation de
Montréal (CEIM)
●
CEIM offers customized management
consulting and related services for the
creation and development of companies
Web site
●
Sectors: information technology, new media,
clean technology and life sciences
NRC (Boucherville)
● Provides space for innovative companies
● Access to NRC expertise in photonics,
microfluidics and material science
Web site
Web site
AN ENVIRONMENT CONDUCIVE TO INNOVATION
SECTOR | MEDICAL TECHNOLOGIES
17
UNIVERSITY BASED
TECHNOLOGY TRANSFER ORGANISATIONS
Univalor
●
●
Accelerating the transfer of the results of
research, conducted by researchers at the
University of Montreal and its schools and
most of its affiliated hospitals, to industry
MSBi Valorisation (MSBiV)
●
Achievements : 10 active spin-offs, $1,5
million in third party investment in spin-offs,
460 000 $ grant to spin-offs, 139 patents and
178 patent applications in progress
Web site
●
Provides capital, manpower and business
sense to monetize promising technologies
developed within:

McGill University

Université de Sherbrooke

Bishop’s University

As well as from affiliated hospitals and
research centers
Since 2001:
Gestion Valeo

12 spin-out companies (6 in LSHT)
●
To commercialize the results of research
carried out by the member universities of the
INRS-Université du Québec network

3,3 M$ invested in tech transfer and spin
out companies

Leverage factor above 50
●
In Montréal: École de technologie supérieure
(ETS), l’Université du Québec à Montréal
(UQAM), l’INRS-Institut-Armand Frappier
Web site
●
5 spin-out companies (2 in LSHT)
Web site
AN ENVIRONMENT CONDUCIVE TO INNOVATION
SECTOR | MEDICAL TECHNOLOGIES
18
THE QUEBEC NATIONAL POLICY
ON RESEARCH AND INNOVATION (PNRI)
The Government of Québec presents its new innovation policy in October 2013
 The Politique nationale de la recherche et de l’innovation (PNRI) confirms the support offered
by the Government of Quebec to different components of R&D and of the innovation process
including continuing support to innovative companies and to the commercialisation of research
A comprehensive innovation strategy while maintaining key programs
 A plan for investing $ 3,7 billion over 5 years
 Seven high priority fields of activities including the following two in LSHT:
biotechnologies and personalized healthcare
 Continuing support to SR&ED tax credits, one of the most competitive programs in the world
 Incentives to innovative companies: support for first patent application, to hiring graduates in
their first research jobs, to start-up companies
 Increased financial support to university research funds along with long term commitment
 Increased budget for the College Technology Transfer Centers (CCTT)
CCTT in health technologies and related areas
 Centre de développement des composites du Québec (CDCQ): www.cdcq.qc.ca
 Centre de solutions technologiques en orthèses et prothèses (CSTOP): www.cstop.ca
 Institut international de logistique de Montréal – IILM: www.iilm.ca
 Vestechpro – Centre de recherche et d’innovation en habillement: www.vestechpro.com
AN ENVIRONMENT CONDUCIVE TO INNOVATION
SECTOR | MEDICAL TECHNOLOGIES
19
A HOT SPOT OF OPEN INNOVATION
AND COLLABORATIVE RESEARCH
Incentives to collaborative research (Government of Québec)
 Tax credits at the applicable rate1 :
 on 80% of eligible expenditures in connection with a research contract with a university or
an eligible research center
 on half of the fees paid to a subcontractor at arm’s length who performed R&D on behalf of
the corporation in Québec
 on contribution paid to a research consortium or expenditures made in connection with precompetitive research project based on a private partnership
 Creation and funding of formal research consortia, by sector, to promote pre-competitive
research and enhance the transfer of knowledge between public labs and companies
MEDTEQ - Le consortium de recherche industrielle et d’innovation en technologies
médicales du Québec Web site
 Mission: to accelerate the development of new medical technologies for the benefit of clinicians
and patients; validate their contribution to healthcare systems and their positioning on
international markets
 Aims at facilitating networking between partners of the innovation process in med tech
 Targets inter-sectorial multidisciplinary projects, involving several partners (minimum of two
companies and one public laboratory)
 Matches amounts invested by private companies up to 25% of the project costs
1 : «Taxation in Québec», Invest-Québec
http://www.invest-quebec.com/documents/int/publications/FiscaliteQC2013_en.pdf
GREATER MONTREAL,
SECTOR | MEDICAL TECHNOLOGIES
20
A LEADING VENTURE CAPITAL CENTER IN CANADA
Réseau Capital
 The only private equity association that brings together all stakeholders involved in the
Quebec investment chain - Web site
Key statistics
 Between 2001 and 2011, venture capital investments in Montreal-based companies of
the LSHT sector exceeded 1,6 G$. The region collected near 33% of the Canadian total
– the highest in Canada for this sector.1
 Investments from venture capital funds are coming back in Quebec as shown by the
following indicators 2 :
●

In 2012, VC funds raised the highest amount of capital in 10 years (924 M$)

433 M$ were invested during the first half of 2013 in all sectors

41% of all funds available in Canada for the LSHT sector are to be found in Montreal
In September 2013, BDC Venture Capital3 allocated $135 million in new capital to direct
venture investments in innovative healthcare technology companies
1 : Profil_svts2013-1.pdf de www.montreal-invivo.com ; Thomson Reuters, 2012
2 : http://reseaucapital.com/nouvelles.php
3 http://www.bdc.ca/FR/solutions/capital_risque/salle_nouvelles/Pages/default.aspx#.Um6C2BBcnp4
TARGETED AND
SECTOR | MEDICAL TECHNOLOGIES
21
HIGHLY COMPETITIVE INCENTIVES
Tax burden on business in R&D: almost 5 times less than the average of 19 other major
North American cities
Cost-benefit due to R&D Tax credit
Index of overall tax burden, average for R&D sectors
(average of cities located in the United States = 100)
Top 20 largest cities in North America, 2012
120
100
80
60
40
20
0
N.B. : Exchange rate 1 $ US = 1 $ CA
Refer to Appendix 6 for methodology - Source : KPMG, 2012
TARGETED AND
SECTOR | MEDICAL TECHNOLOGIES
22
HIGHLY COMPETITIVE INCENTIVES(CONT’D)
Tax credit for scientific research
and development
15 % allocated by the government of
Canada and 17.5% by government
of Quebec
(the latter being refundable)
Scenario ($) No1
Scientific research and experimental development (SR&ED), 2011
HYPOTHESIS1
The company is private under foreign control
20 eligible employees @ 50 000 $/year
100 % of their work is eligible
Subcontractor : 200 000 $
Equipment : 150 000 $
Salary ($)
FEDERAL
QUEBEC
1 000 000
1 000 000
Proxy method for overhead @ 55 %
550 000
Subcontractors2
160 000
Equipments
150 000
SR&ED credit of Quebec3
Federal credit @ 20 % and
Quebec credit @ 17,5 %
TOTAL
100 000
-192 500
1 517 500
1 100 000
554 000
227 625
192 500
420 000
N.B. :
1
This model considers the recent changes to the tax credit for scientific research and development (2012) and
therefore is valid from the 2014 fiscal year.
2
Only 80% federal and 50% in Quebec of the amount paid to the subcontractor is eligible for the credit.
3
In calculating the combined credit, the rate of provincial tax credit is applied to reduce the federal tax credit.
Source : Deloitte, Tax Incentive Programs in Québec – IT, January 2011
TARGETED AND
SECTOR | MEDICAL TECHNOLOGIES
23
HIGHLY COMPETITIVE INCENTIVES (CONT’D)
Tax holiday for researchers and
international experts
Financial assistance for job creation
and training
Tax exemption on taxable income in Quebec for 25 % of eligible costs for implantation of training
a period of five years:
plans and 50 % of the costs for setting up a
management service of human resources
1st - 2nd years : 100 %
3rd :
75 %
th
4 :
50 %
th
5 :
25 %
And more…
24
MONTREAL
INTERNATIONAL :
CUSTOMIZED
SERVICES
MONTREAL INTERNATIONAL :
SECTOR | MEDICAL TECHNOLOGIES
25
CUSTOMIZED SERVICES
Strategic support for different projects
(implementation, expansion or strategic
alliances)
Knowledge of financial and tax programs
Assistance to expatriates in their approaches
to obtain official documents
Access to specialized professionals in
knowledge-based sectors
Assistance in the selection of investment site
via a comprehensive range of key
comparative data
Linking with strategic actors of Greater
Montreal
CONTACT
Ms. Ginette Audet, Ec. D.
DIRECTOR, BUSINESS DEVELOPMENT
INVESTMENT GREATER MONTREAL
Life Sciences
Office :
Cellular :
514 987-9379
514 862-2978
Ginette.audet@montrealinternational.com
380, rue Saint-Antoine Ouest
Bureau 8000
Montréal (Québec) H2Y 3X7
Business in Greater Montréal –
Montréal International
Téléphone :
Télécopieur :
@MontrealIntl
@IntlOrgMontreal
@talentmontreal
514 987-8191
514 987-1948
www.montrealinternational.com
27
APPENDICES
SECTOR | MEDICAL TECHNOLOGIES
ANNEXES
28
APPENDIX 1 : PRESENTATION OF MONTREAL-INVIVO - CLUSTER OF LSHT
- Multinational pharmaceutical companies with Canadian headquarters in the Montreal area as AbbVie , Bristol Myers Squibb Canada , GlaxoSmithKline, Abbott Laboratories, Merck Canada , Novartis Pharmaceuticals Canada
, Pfizer Canada , Sanofi and Servier Canada Business.
- Greater Montréal’s health technologies industry: consisting Innovative, international-calibre companies such as
Covidien, Elekta, Medtronic of Canada, TELUS Health Solutions, Zimmer CAS, etc. and a large number of locally
based and highly creative SMEs such as Carré Technologies, Emovi, Kinova, etc..
- Biotechnology : number of companies with headquarters in Montreal as AlethiaBiotherapeutics , Bio- K Plus
International Caprion, MethylGene, Theratechnologies, Vertex Pharmaceuticals (Canada).
- Contract manufacturing research: offering a complete array of services ranging from preclinical studies to
therapeutic drug monitoring in compliance with Good Manufacturing Practices (GMP); among which: Algorithme
Pharma Cato Recherche Canada COREALIS Pharma Inc. Laboratoires Charles River Services Précliniques
Montréal Laboratoires ITR Canada Quintiles Canada Recherche Clinique ICON (Canada) Uman Pharma.
- Greater Montréal, a natural bridge between North America and Europe and an ideal location for companies
looking to expand into foreign markets: In 2012, Greater Montréal’s LSHT industry exported over $820 million
worth of goods. Between 2006 and 2012, the region’s LSHT exports represented $5 billion.
Source :Profil_svts2013-1.pdf from www.montreal-invivo.com , with the collaboration of Montreal International
SECTOR | MEDICAL TECHNOLOGIES
ANNEXES
29
APPENDIX 2 : COMPANIES
MEDICAL DEVICES & TECHNOLOGIES
Company
Web site
Field of activity
AMD Ritmed

Dressings, OR supplies and specialty surgical products
Analogic Canada

Digital mammography imaging systems and flat panel detectors
atms

Traceability solutions for the reprocessing of medical devices and
OR linens in healthcare facilities
Bavaria Medical Technology Canada

Catheters
Baylis Medical Company

Supplier of high-technology cardiology, endovascular and oncology
devices
bioMérieux Canada

Diagnostic solutions (reagents, instruments, software) that
determine the source of disease and contamination
Biomod

Vectorization technologies for the delivery of active ingredients via
the skin
Biomomentum

Solutions for the biomechanical evaluation of tissues, biomaterials,
and cartilage
Biotonix

Imaging system for postural analysis to ensure optimal spinal health
and overall fitness
Bracco Imaging Canada

Contrast agents and solutions for medical imaging systems
SECTOR | MEDICAL TECHNOLOGIES
ANNEXES
30
APPENDIX 2 : COMPANIES
MEDICAL DEVICES & TECHNOLOGIES (Cont’d)
Company
Web site
Field of activity
Cardinal Health Canada

Distributor of medical and surgical products
Carré Technologies

Software and devices to monitor and record biosignals for real-time
or delayed analysis
Citagenix

Devices and materials for bone regeneration
Clemex Technologies

Scientific image analysis solutions for quantitative microscopy
CogniSens

Devices for measuring, identifying and improving neurobiological
activity
ConvaTec

Devices and supplies for stomacare, wound therapeutics and skin
care
Coroneo

Medical devices for the field of cardiac surgery
Covidien

Distributor of medical devices and medical supplies
DenPlus

Designs, manufactures and distributes dental products
Dymedso

Introduction of new medical technologies to help those suffering
from chronic respiratory diseases
SECTOR | MEDICAL TECHNOLOGIES
ANNEXES
31
APPENDIX 2 : COMPANIES
MEDICAL DEVICES & TECHNOLOGIES (Cont’d)
Company
Web site
Field of activity
Elekta Canada

Systems for image guided radiation therapy of soft tissues using
latest generation, 3-D ultrasound technology
EMcision

Medical devices based on proven RF technology for the surgical
community, endoscopists and interventional radiologists
emd Technologies

High-voltage advanced power electronics components targeted at
the medical X-ray field
Emovi

System for dynamic 3D evaluation of knee motion
Ergoresearch

Markets “intelligent” foot orthotics and specialty orthotics as well as
software for the orthopedics; runs a network of orthotics clinics
Fresenius Medical Care

Devices and supplies for kidney dialysis
Gambro

Products and therapies for kidney and liver dialysis
Genia Photonics

Laser based solutions and cost effective photonics for medical
imaging
Héma-Québec

Supplies safe, optimal blood components, substitutes, human
tissues and cord blood to meet the needs of Quebec population
Invacare Canada

Devices, equipment and products for rehab and home care
SECTOR | MEDICAL TECHNOLOGIES
ANNEXES
32
APPENDIX 2 : COMPANIES
MEDICAL DEVICES & TECHNOLOGIES (Cont’d)
Company
Web site
Field of activity
Kinova Robotics

Six-axis robotic manipulator arm with a three-fingered hand for
persons with upper body mobility impairment
Klox Technologies

Therapeutic and cosmetic solutions based on a biophotonics
system coupled with a light-trapping gel
Laborie Medical Technologies

Innovative medical equipment and catheters in urology and
gynecology
Lantheus Medical Imaging

Diagnostic medical imaging agents and reagents
Maetta

Specialized in powder injection molding for implants and orthopedic
instruments
Masimo Canada

Manufactures innovative noninvasive patient monitoring
technologies, medical devices and a wide array of sensors
Medical Plastic Devices

Provides precision injection molding services to the healthcare
industry
MIT Canada

Manufacturing and marketing of needle free jet injectors for
veterinary and human applications
Medtronic Cryocath

Catheter-based cryotherapy products to treat cardiovascular
diseases
MedXL

Designs and manufactures medical devices and prefilled syringes
Menodys

Market innovative medical devices for improved health care
SECTOR | MEDICAL TECHNOLOGIES
ANNEXES
33
APPENDIX 2 : COMPANIES
MEDICAL DEVICES & TECHNOLOGIES (Cont’d)
Company
Web site
Field of activity
NexPlasmaGen

Portable plasma-based medical instruments for wound healing and
skin treatments
Noveko International

Antimicrobial surgical masks, respirators and air filters derived from
its patented antimicrobial filtration technology
Octostop

Filters for X-ray procedures and systems for pediatric
immobilisation
Oligo Medic

Injectable gels for joint and cartilage repair
Optina Diagnostics

Ocular imaging system based on super-spectral analysis
pDevices

Miniature portable plasma based medical diagnostic device
Pega Medical

Orthopedic instrumentation and pediatric implants
Photon etc.

Application of hyperspectral analysis to ophtalmology and
dermatology
Piramal Healthcare Innovation

Products based on a biopolymer technology platform for enhancing
the process of cartilage regeneration
Positech Innovation

Cushions, and postural aid systems for to improve clients’ posture
while providing them with maximum comfort and autonomy
SECTOR | MEDICAL TECHNOLOGIES
ANNEXES
34
APPENDIX 2 : COMPANIES
MEDICAL DEVICES & TECHNOLOGIES (Cont’d)
Company
Web site
Field of activity
QSD

Manufacture of seamless compression apparel for post surgical
recovery devices, athletic wear and orthopedic garments
Rheolution

Instruments for the analysis of materials mechanical performance
for biomedical applications and the study of biological tissues
Roche Diagnostics Canada

Range of rapid, reliable instruments and tests for disease screening
and diagnosis in laboratories, at the point of care, and for patient
self-management
Rogue Research

Neuronavigation products for application in the fields of cognitive
neuroscience, rehabilitation research and veterinary sciences
SCIREQ

Design and manufacture of precision laboratory equipment and
data monitoring systems for preclinical pulmonary research
Smith & Nephew

Diversified medical technology company
Surgmed

Manufacturing and distribution of medical supplies and surgical
products
Synergie Médicale BRG

Automated dispensing system for solid oral medication
Thought Technologies

Manufacturer of instruments for biofeedback, neurofeedback, and
psychophysiological studies
ZimmerCAS

Computer assisted surgical navigation system based on the
Orthosoft platform to improve the outcomes of knee and hip
replacement surgery
SECTOR | MEDICAL TECHNOLOGIES
ANNEXES
35
APPENDIX 2 : COMPANIES
e-HEALTH & TELEMEDICINE
Company
Web site
Field of activity
Aptimed

e-learning platform for health professionals in Canada and abroad
Bell Solutions Santé

Portal for accessing computerized medical records and for the
management of chronic diseases; development of mobile clinical
carts for tele-health applications.
CAE Santé

Patient simulators, surgical simulators, imaging simulators and
courseware for healthcare professionals
Christie Innomed

IT clinical systems and products related to medical imaging
Fujitsu Canada

Services, equipment and software to improve the delivery of
healthcare services
Groupe CGI

Integrator of computerized management systems with applications
to the healthcare sector
Intelerad

Supplier of archiving and image transmission system (PACS) as
per DICOM standards
Logibec

Business software and computer services for the healthcare and
social services sectors
Manyeta

Home-base patient monitoring system which allows systemic
monitoring of the patient’s metabolic condition
McKesson Canada

A complete range of solutions to improve quality, security and cost
for patient’s care
SECTOR | MEDICAL TECHNOLOGIES
ANNEXES
36
APPENDIX 2 : COMPANIES
e-HEALTH & TELEMEDICINE (Cont’d)
Company
Web site
Field of activity
MediSolution

Administrative software designed specifically to meet the operating
data of laboratory computerization needs
Omnimed

Software for the patient’s electronic record including speedy access
and management of clinical data
PeriGen

Provider of fetal surveillance software and systems
PHD Medical

Products and services to meet specific needs of the home
diagnostic and telemedicine markets
Purkinje

Data management systems for healthcare centers
Shimadzu Software Development
Canada

Development and maintenance of DICOM compliant medical
software and image processing methods for the company’s
cardiology and RF platforms
SOGIQUE

Branch of the MSSS to support the management of Quebec
healthcare computer network
TELUS Santé

Specialized telecommunication services for electronic medical files;
OASIS transmission systems for laboratory analyses
Vigilent Telesystems

Software and robotic camera systems used in telemedicine, in
teletraumatology and patient’s remote monitoring
ZoomMed

A clinical interoperable information exchange network between
physicians and various other stakeholders of the healthcare sector
SECTOR | MEDICAL TECHNOLOGIES
ANNEXES
37
APPENDIX 3 : RESEARCH CENTERS & INSTITUTES
Centre de recherche – Centre hospitalier de l’Université de Montréal (CHUM)
http://crchum.com/crchum.fr.html
Contact : Jacques Turgeon, Directeur
Centre de recherche – Centre universitaire de santé de McGill (CUSM)
http://cusm.ca/research/dashboard
Contact : Vassilios Papadopoulos,, D. Pharm., Ph.D., Directeur exécutif et scientifique en chef
Centre de recherche – CHU Sainte-Justine
http://www.chu-sainte-justine.org/recherche/
Contact : Alain Moreau, Ph.D., Directeur de la recherche
Centre de recherche Fernand-Seguin – Institut universitaire en santé mentale de Montréal
http://www.iusmm.ca/recherche.html
Contact : Sonia Lupien, Ph.D., Directrice scientifique
Centre de recherche - Hôpital général juif – Institut Lady Davis de recherches médicales
http://ladydavis.ca/fr/home
Contact: Roderick R. McInnes, MD, PhD, Directeur
Centre de recherche – Hôpital Maisonneuve-Rosemont
http://recherche.maisonneuve-rosemont.org/
Contact : Denis Claude Roy, M.D., Directeur
SECTOR | MEDICAL TECHNOLOGIES
ANNEXES
38
APPENDIX 3 : RESEARCH CENTERS & INSTITUTES
Centre de recherche - Hôpital de Montréal pour enfants
http://www.hopitalpourenfants.com/la-recherche
Contact : Jacquetta Trasler, M.D., Ph.D., Directrice, recherche en santé de l’enfant
Centre de recherche – Hôpital du Sacré-Cœur de Montréal
http://www.crhscm.ca/
Contact : François Madore, M.D., Directeur de la recherche
Centre de recherche – Institut et hôpital neurologiques de Montréal
http://francais.mni.mcgill.ca/
Contact : Guy A. Rouleau, M.D., Ph.D., Directeur
Centre de recherche – Institut Philippe-Pinel de Montréal
http://www.pinel.qc.ca/GeneralList.aspx?NavID=293&CultureCode=fr-CA
Contact : Gilles Côté, Ph.D., Directeur
Centre de recherche – Institut de cardiologie de Montréal
http://www.icm-mhi.org/fr/recherche/propos-centre-recherche
Contact : Jean-Claude Tardif, M.D., Directeur
Centre de recherche - Institut universitaire de gériatrie de Montréal (CRIUGM)
http://www.criugm.qc.ca/
Contact : Sylvie Belleville, Ph.D. Directrice scientifique
SECTOR | MEDICAL TECHNOLOGIES
ANNEXES
39
APPENDIX 3 : RESEARCH CENTERS & INSTITUTES
Centre de recherche - Institut universitaire en santé mentale Douglas
http://www.douglas.qc.ca/
Contact : Brigitte L. Kiefer, Ph.D., Directrice scientifique
Centre de recherche interdisciplinaire en réadaptation du Montréal métropolitain (CRIR)
http://www.crir.ca/?84879747-0EEE-4FA6-878C-B927C1EA76A4
Contacts :Eva Kehayia & Bonnie R. Swaine, Directrices scientifiques
Institut de réadaptation Gingras-Lindsay-de-Montréal (IRGLM)
http://www.irglm.qc.ca/recherche/la-recherche-a-lirglm.php
Contact :Lise Poissant, Directrice de la recherche
Institut de recherche clinique de Montréal (IRCM)
http://www.ircm.qc.ca/IRCM/Pages/default.aspx?PFLG=1036&lan=1036
Contact : Dr Tarik Möröy, Ph.D., Président et directeur scientifique
Institut de recherche Robert-Sauvé en santé et en sécurité du travail du Québec (IRSST)
http://www.irsst.qc.ca/
Contact : Marie Larue, Présidente-directrice générale
Institut du cancer de Montréal (ICM)
http://www.icm.qc.ca/cgi-cs/cs.waframe.index?lang=1
Contact : Anne-Marie Mes-Masson, Ph.D., Directrice scientifique
SECTOR | MEDICAL TECHNOLOGIES
ANNEXES
40
APPENDIX 3 : RESEARCH CENTERS & INSTITUTES
Centre de recherche en sciences et technologies biomédicales (GRSTB)
http://www.groupes.polymtl.ca/grstb/
Contact : Michael D. Buschmann, B.Eng., Ph.D., Directeur; michael.buschmann@polymtl.ca
Centre PERFORM de l’Université Concordia
http://performcentre.concordia.ca/fr/
Contact : Kevin Little, Directeur général; Kevin.Little@concordia.ca
Département de génie biomédical de McGill
http://www.bmed.mcgill.ca/
Contact: Robert E. Kearney, Président du département; robert.kearney@mcgill.ca
Institut de génie biomédical
http://www.igb.umontreal.ca/
Contact : Pierre Savard, Directeur; pierre.savard@polymtl.ca
Laboratoire de recherche en imagerie et orthopédie (LIO)
http://www.etsmtl.ca/Unites-de-recherche/lio/accueil
Contact : Jacques A. de Guise, Ph.D., ing. Titulaire; jacques.deguise@etsmtl.ca
Laboratoire d'imagerie, de vision et d'intelligence artificielle (LIVIA)
http://www.etsmtl.ca/Unites-de-recherche/LIVIA/accueil
Contact : Robert Sabourin, Directeur; robert.sabourin@etsmtl.ca
SECTOR | MEDICAL TECHNOLOGIES
ANNEXES
41
APPENDIX 4 : RESEARCH CHAIRS
Chaire industrielle de recherche en technologies intra-auriculaires Sonomax-ÉTS – CRITIAS
http://www.etsmtl.ca/Recherche/Chaires-unites-rech/Chaires/Chaire-CRITIAS
Contact : Jérémie Voix, Titulaire; jeremie.voix@etsmtl.ca
Chaire de recherche du Canada en imagerie 3D et ingénierie biomédicale
http://chairei3dib.etsmtl.ca/
Contact : Jacques A. de Guise, Ph.D., Ing., Titulaire; jacques.deguise@etsmtl.ca
Chaire de recherche du Canada sur les biomatériaux et implants endovasculaires
http://www.etsmtl.ca/Chaires-de-recherche/Chaire-biomateriaux/Accueil?lang=fr-CA
Contact : Sophie Lerouge, MÉC, Titulaire; sophie.lerouge@etsmtl.ca
Chaire de recherche Marie-Lou et Yves Cotrel en orthopédie du CHUM et de l'Université de Montréal (Soutenue par la Fondation
de l'ÉTS)
http://en.etsmtl.ca/Unites-de-recherche/LIO/Recherche-et-innovation/Chaires
Contact : Jacques A. de Guise, Ph.D., Ing., Titulaire; jacques.deguise@etsmtl.ca
Chaire de recherche ÉTS en traumatologie vertébro-médullaire
http://www.etsmtl.ca/Recherche/Chaires-unites-rech/Chaires/CRI-traumatologie
Contact : Yvan Petit, Titulaire,; yvan.petit@etsmtl.ca
SECTOR | MEDICAL TECHNOLOGIES
ANNEXES
42
APPENDIX 4 : RESEARCH CHAIRS
Chaire de recherche du Canada en communications sans fil à haute vitesse
http://www.chairs-chaires.gc.ca/chairholders-titulaires/profile-fra.aspx?profileId=803
Contact : Sofiène Affes, Titulaire; affes@emt.inrs.ca
Chaire de recherche du Canada en photonique ultrarapide appliquée aux matériaux et aux systèmeshttp://www.chairschaires.gc.ca/chairholders-titulaires/profile-fra.aspx?profileId=60
Contact : Jean-Claude Kieffer, Titulaire; kieffer@emt.inrs.ca
Chaire de recherche du Canada en plasmas appliqués aux technologies de micro et de nanofabrication
http://www.chairs-chaires.gc.ca/chairholders-titulaires/profile-fra.aspx?profileId=817
Contact: Mohamad Chaker, Titulaire; chaker@emt.inrs.ca
Chaire de recherche du Canada en technologies de l’information dans le secteur de la santé (HEC Montréal)
http://neumann.hec.ca/chairetisante/index2.html
Contact : Guy Paré, Ph.D. Titulaire; Guy.pare@hec.ca
Chaire de recherche du Canada sur les Innovations en santé
http://www.medsp.umontreal.ca/crcinnovations/
Contact : Pascale Lehoux, Titulaire; pascale.lehoux@umontreal.ca
Chaire de recherche du Canada sur les dispositifs médicaux intelligents (DMI)
http://www.polymtl.ca/recherche/rc/unites/details.php?NoUnite=119
Contact: Mohamad Sawan, Titulaire; mohamad.sawan@polymtl.ca